Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

NCT00437476 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Hepatitis C

Interventions

DRUG: LPV/r
DRUG: Nucleoside Reverse Transcriptase Inhibitors
DRUG: PEG-IFNa 2a
DRUG: Ribavirin

Sponsor

IRCCS San Raffaele

Collaborators

[object Object]
[object Object]